US EPA

7439550 

Journal Article 

Medical Management of Endometriosis, Present and Future with Special Reference to MHT in the Patient Previously Diagnosed with Endometriosis 

de Villiers, TJ; , 

2021 

149-157 

10.1007/978-3-030-57866-4_14 

http://link.springer.com/10.1007/978-3-030-57866-4_14
Exit
 

The endometrium is the unique inner lining of the uterus that responds to the cyclical ovarian hormones estrogen and progesterone with the ultimate aim of providing a suitable implantation environment for the developing embryo. Endometriosis is defined as the presence of endometrial-like tissue outside the uterus that induces a chronic, inflammatory reaction [1]. Endometriosis is a chronic and incurable disease that causes pain and is associated with infertility. Adenomyosis is an associated condition where the endometrial tissue exists within and grows into the uterine myometrium. Adenomyosis will not be specifically addressed in this chapter. The aim of this chapter is to empower the reader with the options of hormonal treatment in endometriosis. Insight into the mechanism of actions, efficacy, and side-effect profile will enable the reader to individualize treatment to the best benefit of the victims of endometriosis.